RobertPFrantzMD
Cardiology • Rochester, MNAdult Congenital Heart Disease, Heart Failure & Transplantation
Cardiology at Mayo Clinic Rochester MN
Dr. Frantz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St SW
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of RochesterFellowship, Cardiovascular Disease, 1987 - 1990
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1984 - 1987- Mayo Clinic College of MedicineClass of 1984
Certifications & Licensure
NY State Medical License 1987 - Present
IA State Medical License 1993 - 2026
ND State Medical License 2009 - 2026
MN State Medical License 1985 - 2025
WI State Medical License 2014 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Clinical Trials
- Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Start of enrollment: 2009 Dec 01
- Modulating Effects of Lisinopril on Sildenafil Activity in Pulmonary Arterial Hypertension(PAH)( MELISSA) Start of enrollment: 2008 May 01
- Clinical Study of Macitentan in Patients With Pulmonary Arterial Hypertension to Psychometrically Validate the PAH-SYMPACT Instrument Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsNon-invasive prediction of pulmonary vascular disease-related exercise intolerance and survival in non-group 1 pulmonary hypertension.Yogesh N V Reddy, Hilary Dubrock, Paul M Hassoun, Anna Hemnes, Evelyn Horn
European Journal of Heart Failure. 2024-11-01 - 3 citationsRisk stratification and treatment goals in pulmonary arterial hypertension.Fabio Dardi, Athénaïs Boucly, Raymond Benza, Robert Frantz, Valentina Mercurio
The European Respiratory Journal. 2024-10-01 - Reduction in Balloon Pump Size Reduces Axillary Intraaortic Balloon Pump Failure Risk.Sara S Inglis, Ardaas Kanwar, Hilda Gonzalez Bonilla, Swaiman Singh, Jennifer Y Pearson
ASAIO Journal. 2024-07-09
Authored Content
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Long-Term Sirolimus for Primary Immunosuppression in Heart Transplant RecipientsFebruary 2018
- Join now to see all
Press Mentions
Episode 475 - Robert Frantz, MDJuly 1st, 2024- Novel PAH Drug Shows Promise in Mid-Stage TrialMay 23rd, 2023
I’m Aware That I’m Rare: Robert P. Frantz, MDNovember 16th, 2018- Join now to see all
Grant Support
- Sildenafil On Alveolar-Capillary Recruitment, Pulmonary Arterial Pressures And ENational Center For Research Resources2005
- Pulmonary Limitations In Chronic Heart FAILURE: Influence Of ACE Genotype On ExeNational Center For Research Resources2005
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
